![](/img/cover-not-exists.png)
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
Joseph P. McEvoy, Jonathan M. Meyer, Donald C. Goff, Henry A. Nasrallah, Sonia M. Davis, Lisa Sullivan, Herbert Y. Meltzer, John Hsiao, T. Scott Stroup, Jeffrey A. LiebermanVolume:
80
Year:
2005
Language:
english
DOI:
10.1016/j.schres.2005.07.014
File:
PDF, 157 KB
english, 2005